Royalty Pharma plc cotiza a 56.93 USD y tiene una capitalización bursátil de $25.3B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $1.32 | $1.30 | $1.47 |
| Estimado | $1.18 | $1.27 | $1.18 | $1.33 |
| Sorpresa | — | +3.9% | +10.2% | +10.5% |
| Métrica | RPRX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 65.6% | -38.6% | +104.2% |
| Net Margin | 32.4% | -33.6% | +66.0% |
| FCF Margin | — | -13.9% | — |
| ROE | 7.9% | -40.4% | +48.3% |
| ROA | 3.9% | -32.0% | +35.9% |
| Current Ratio | 2.40 | 2.84 | -0.44 |
| Debt / Equity | 0.92 | 0.28 | +0.64 |